| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/04/2006 | US7071312 Epidermal differentiation factor |
| 07/04/2006 | US7071310 Antibody against the human toll- like receptor 2 (tlr2) and uses thereof |
| 07/04/2006 | US7071308 Cytokine receptor |
| 07/04/2006 | US7071307 Nucleic acids and proteins with thioredoxin reductase activity |
| 07/04/2006 | US7071306 AMPA-binding human GluR4 receptors |
| 07/04/2006 | US7071305 Human transport protein; brain and kidney analysis; animal models; drug screening; nephrotoxicity; removal of toxic anions from circulatory system |
| 07/04/2006 | US7071302 Isolated protein, and amino acid sequence thereof from caenorhabditis elegans genes ced-3 and ced-4 |
| 07/04/2006 | US7071301 Supplying vector; amino acid sequence for binding virus; modifying sequence for binding second virus; genetic engineered polypeptide |
| 07/04/2006 | US7071294 Tumor antigen protein art-1 and tumor antigen peptide thereof |
| 07/04/2006 | US7071172 Secretion signal vectors |
| 07/04/2006 | US7071160 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 07/04/2006 | US7071159 Solubility forms; skin disorders, rheumatic disorders, antidiabetic agents |
| 07/04/2006 | US7071004 Isolated nucleic acids; uisng gene expression as indicator of cancer; insertion gene in transgenic animals |
| 07/04/2006 | US7070998 Supplying Dna to cells; genetic engineering genomes; therapy for central nervous system diosrders |
| 07/04/2006 | US7070997 Controlling gene expression, apoptosis in plants |
| 07/04/2006 | US7070996 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery |
| 07/04/2006 | US7070995 CE7-specific redirected immune cells |
| 07/04/2006 | US7070994 genetic engineered retrovirus; from transgenic animals; drug transport |
| 07/04/2006 | US7070993 Lentiviral packaging constructs |
| 07/04/2006 | US7070992 Improved efficiency of gene expression |
| 07/04/2006 | US7070991 Cells expressing a CD4-IgG2 chimeric heterotetramer |
| 07/04/2006 | US7070990 Mutant nucleic acid; applying to textiles; animal feeds; genetic engineering |
| 07/04/2006 | US7070989 Genetic engineered plasmid vectors; antibiotic resistance; anticancer agents |
| 07/04/2006 | US7070986 Proteases from gram positive organisms |
| 07/04/2006 | US7070982 Bacillus chimeric crystal protein with enhanced insecticidal for use in generating and propagating insect resistant plants; biological control agents; pest control |
| 07/04/2006 | US7070981 Gene 763 of phytopathogenic fungus Magnaporthe grisea and use thereof for identifying fungicidal compounds |
| 07/04/2006 | US7070980 Midecamycin biosynthetic genes |
| 07/04/2006 | US7070979 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/04/2006 | US7070978 Expression of preferential protein in in culture; obtain cell, transfrom with vecro containg preferential protein, express vector, lyse cell, recover protein |
| 07/04/2006 | US7070977 Human serine protease D-G polypeptide |
| 07/04/2006 | US7070975 Comprises disintegrin enzymatic polypeptide for use in the identification of modulators for treatment of bone, vision and respiratory system disorders; enzyme inhibitors |
| 07/04/2006 | US7070974 Polymerase chain reactions; cloning; screening Dna libraries; fusion protein in Escherichia; forming antibodies; isolated nucleic acid |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070970 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid |
| 07/04/2006 | US7070969 Plasmin inhibitors from the australian brown snake Pseudonaja textilis textilis |
| 07/04/2006 | US7070967 Fermentation using Saccharomyces |
| 07/04/2006 | US7070963 Amidase from variovorax |
| 07/04/2006 | US7070961 Amplifying preferential target nucleic acids; obtain biochip, couple nucleotide sequences to chip, incubate with sample containing target nucleotide sequences, expose to primer, amplify and recover nucleotids sequences |
| 07/04/2006 | US7070959 Prevent blood leakage or vacular system permeability; isolated nucleic acid; fusion protein containing endothelial growth factor and immunoglobulins |
| 07/04/2006 | US7070956 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 07/04/2006 | US7070955 Comprises nucleotide sequences coding membrane proteins for diagnosing, preventing and treating inflammatory, cell proliferative and autoimmune diseases |
| 07/04/2006 | US7070954 Detection of human genes; sensitivity to cancer and blood disorders; Down's syndrome; isolation of nucleic acids; drug screening |
| 07/04/2006 | US7070952 Genes encoding carotenoid compounds |
| 07/04/2006 | US7070947 Human protein kinase, phosphatase, and protease family members and uses thereof |
| 07/04/2006 | US7070946 Polypeptide for use in the diagnosis and treatment of bone disorders |
| 07/04/2006 | US7070938 Measuring activity of endothelial growth factor modulator; obtain modulator, incubate with kinase, isolate phosphorylated substrate, remove label, detecting adjustment in kinase activity |
| 07/04/2006 | US7070935 Method for detecting a biological entity in a sample |
| 07/04/2006 | US7070934 Genetic engineered zinc finger domain; hormone receptors transcription control; polynucleotides; modulate gene expression; generation transgenic plants, animals |
| 07/04/2006 | US7070930 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus |
| 07/04/2006 | US7070928 Evolving new molecular function |
| 07/04/2006 | US7070926 Chimaeric phages |
| 07/04/2006 | US7070819 metalloprotease having a specific amino acid sequence and further comprising an animal feed enzyme premix, a bacteriolytic enzyme, a xylanase, a subtilisin protease, a cellulase and a beta-glucanase |
| 07/04/2006 | US7070807 Administering polypeptide by injection; gene therapy |
| 07/04/2006 | US7070793 Antigen protein and nucleic acid coding for said protein |
| 07/04/2006 | US7070792 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 07/04/2006 | US7070791 Comprises genetically engineered bacteriophage polymerase for detection and treatment of microorganismal infections |
| 07/04/2006 | US7070789 Hybrid polypeptides as vaccine |
| 07/04/2006 | US7070788 Adjusted glycoprotein; for use in treatment of cancer |
| 07/04/2006 | US7070784 Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues |
| 07/04/2006 | US7070779 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 07/04/2006 | US7070772 Salicylic acid biosynthetic genes and uses thereof |
| 07/04/2006 | US7070771 Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells |
| 07/04/2006 | US7070739 two dimensional centrifugation on the basis of sedimentation rate and isopycnic banding density through zones of immobilized reagents to which they are resistant, for detecting banded particles by light scatter or fluorescence using dyes; useful in clinical trials of new antibiotics and antivirals |
| 07/04/2006 | US7069690 Demetallization, dephosphatizing; water pollution control |
| 07/04/2006 | CA2396674C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 07/04/2006 | CA2359838C Amplification using modified primers |
| 07/04/2006 | CA2228956C Cdna corresponding to the antigenome of nonsegmented negative strand rna viruses, and process for the production of such viruses encoding additional antigenically active proteins |
| 07/04/2006 | CA2209889C Process for producing trans-4-hydroxy-l-proline |
| 07/04/2006 | CA2205359C Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-beta peptide (x->=41) and tau |
| 06/29/2006 | WO2006069403A2 Methods for producing soluble multi-membrane-spanning proteins |
| 06/29/2006 | WO2006069389A1 Use of flexible bag containers for viral production |
| 06/29/2006 | WO2006069329A2 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 06/29/2006 | WO2006069306A2 A knockout mouse for the tumor suppressor gene anx7 |
| 06/29/2006 | WO2006069290A2 Enzymes for starch processing |
| 06/29/2006 | WO2006069289A2 Polypeptides having glucoamylase activity and polynucleotides encoding same |
| 06/29/2006 | WO2006069253A2 Trefoil factors and methods of treating proliferation disorders using same |
| 06/29/2006 | WO2006069201A2 Plant stress tolerance from modified ap2 transcription factors |
| 06/29/2006 | WO2006069174A2 Simultaneous anaerobic production of isoamyl acetate and succinic acid |
| 06/29/2006 | WO2006069099A2 Method and compositions for rapidly modifying clones |
| 06/29/2006 | WO2006069064A2 Conserved hbv and hcv sequences useful for gene silencing |
| 06/29/2006 | WO2006069017A2 Transgenic plants with enhanced agronomic traits |
| 06/29/2006 | WO2006068975A2 Binding proteins specific for human matriptase |
| 06/29/2006 | WO2006068953A2 Antibodies directed to angiopoietin-2 and uses thereof |
| 06/29/2006 | WO2006068910A1 Glp-1 analog fusion protein formulations |
| 06/29/2006 | WO2006068625A1 Novel snake toxin |
| 06/29/2006 | WO2006068603A1 New transgenic plants and method for their production |
| 06/29/2006 | WO2006068442A1 Use of atbg1 gene for the generation of transgenic plants with increased resistance to various abiotic stress |
| 06/29/2006 | WO2006068432A1 Regulator for flowering time, transgenic plant transformed with the same, and method for regulating flowering time |
| 06/29/2006 | WO2006068326A1 Novel polypeptide and the use thereof |
| 06/29/2006 | WO2006068307A1 Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone |
| 06/29/2006 | WO2006068250A1 Nanographite structure/metal nanoparticle composite |
| 06/29/2006 | WO2006068249A1 Method of obesity test and method of screening of preventive or therapeutic drug for obesity |
| 06/29/2006 | WO2006068239A1 Method of examining inflammatory disease and method of screening remedy for inflammatory disease |
| 06/29/2006 | WO2006068225A1 Method of inducing differentiation of skeletal muscle cell |
| 06/29/2006 | WO2006068187A1 Target physiological function inactivator using photosensitizer-labeled fluorescent protein |
| 06/29/2006 | WO2006068170A1 Method for improvement of heat stability of glucose dehydrogenase |
| 06/29/2006 | WO2006068148A1 Recombinant microorganism |
| 06/29/2006 | WO2006068133A1 Method of suppressing expression of nfat2 |
| 06/29/2006 | WO2006068111A1 Method of determining phenotype assosiated with genetic polymorphism of pparϝ gene |
| 06/29/2006 | WO2006067913A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |